Immunization Schedule - Expanded Programme, WHO recommendations
IMMUNIZATION SCHEDULE
Share
Last Updated : 1/9/2014
Sayenna Uduman
More..
ACIP 2016 immunization schedules and IAP immunization Schedule 2014
The ACIP 2016 immunization schedules for children and adolescents from birth through 18 years of age include several changes from last year, including updated recommendations for the human papillomavirus (HPV) and meningococcal B vaccines. Both the updated schedules (IAP – 2014) and the immunization schedules for 2016 (IAP, ACIP) is summarized in the following two tables:

Table 3: Background summary of Licensed HPV vaccines
Recombinant vaccines Bivalent- HPV 2 (Cervarix) GSK Quadrivalent HPV- 4 (Gardasil 4) Merck Quadrivalent (HPV- 9) Gardasil 9; Merck
Valent types 16 & 18 6, 11, 16 & 18 6, 11, 16, 18, 31, 33, 45, 52, and 58.
Adjuvant ASO4 AAHS  
Licensed Females aged 9 – 25 years Females & Males aged 9 – 26 years Females aged 9-26 & Males aged 9-21
Schedules 3 doses 0 – 1 -6 months 3 doses: 0 -2 -6 months Can start at age nine. Also for females aged 13 to 26 & for males aged 13 to 21 who have not been vaccinated previously or have not completed the 3-dose series.
Immunogenicity-based neutralizing Ab Minimal protective Ab threshold May lose detectable Ab but no loss of protection Licensed for both males & females; expanded HPV9 age indication of 16-26 years for males.


Other IAP recommended vaccines for High-risk* children (Vaccines under special circumstances).
1-Influenza Vaccine, 2-Meningococcal Vaccine. 3-Japanese Encephalitis Vaccine. 4-Cholera Vaccine. 5-Rabies Vaccine. 6-Yellow Fever Vaccine. 7-Pneumococcal Polysaccharide vaccine (PPSV 23)
Highlights from the IAP updated schedule are shown below:
• Now the whole cell pertussis (wP) vaccines are scheduled for the primary series of infant vaccination.
Rotavirus vaccine has been revised to 10 & 14 weeks from existing 6 & 10 weeks of age. Only 2 doses of RV1 (Roderick) are recommended at present. If chosen, 3-dose Rota-teq (RV5) should be completed before 32 weeks of age.
• New typhoid conjugated vaccine (tetanus toxoid conjugated Vi TT) and new meningococcal conjugate vaccines has been introduced (TT conjugated VI-TT).
• To use Tdap vaccine during 2nd or 3rd trimester of each pregnancy to protect neonatal tetanus and pertussis during infancy.

References

Contributor Information and Disclosures

Sayenna Uduman
Sayenna A Uduman MD, FAAP
Visiting Professor, Infection Control Committee & ID Division of the KIMS
Thiruvananthapuram, Kerala, India


First Created : 1/9/2001
Last Updated : 1/9/2014

References

Advertisements by :    Mega-CV by Aristo IndoIV by Sun Pharma
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.